Calithera Biosciences announced topline results from the CANTATA clinical study, which was designed to evaluate the company’s glutaminase inhibitor telaglenastat […]
As TrialSite has reported, Lilly’s Bamlanivimab (or LY-CoV555), despite its hi-tech nature as a monoclonal antibody therapy for COVID-19 with […]
A clinical trial investigating COVID-19 antibodies conducted by the Changhua County Public Health Bureau and National Taiwan University in Taiwan […]
Brainstorm Cell Therapeutics reported topline results from a Phase 3 trial evaluating NurOwn (MSC-NTF cells) as a treatment for Amyotrophic […]
The World Health Organization (WHO) advises against using Remdesivir under any circumstances. Apparently, a prominent group of intensive care doctors […]
Revance Therapeutics reported results from its Phase 2 clinical trial of DaxibotulinumtoxinA for Injection for the management of plantar fasciitis, […]
Jounce Therapeutics announced the phase 2 EMERGE trial will be discontinued following early evaluation of clinical data. The open label […]
Aurinia Pharmaceuticals announced topline data from the Phase 2/3 AUDREY trial evaluating voclosporin ophthalmic solution (VOS) for the potential treatment […]
Catabasis Pharmaceuticals announced top-line results from the Phase 3 PolarisDMD trial of edasalonexent in Duchenne muscular dystrophy (DMD). The trial […]
A recent study out of University of Washington School of Medicine in Seattle further weakens the case for hydroxychloroquine as […]
